Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma

Journal: Cancer Research

Published: 2020-05-01

DOI: 10.1158/0008-5472.can-19-2787

Affiliations: 11

Authors: 23

Go to article
Institutions Share
University of Tsukuba Hospital, University of Tsukuba, Japan 0.32
Faculty of Medicine, University of Tsukuba, Japan 0.14
Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan 0.13
School of Medicine, Kurume University, Japan 0.09
Department of Pathology and Tumor Biology, Kyoto University, Japan 0.09
Hitachi General Hospital, Japan 0.09
Cellules Souches Hématopoïétiques et Développement des Hémopathies Myéloïdes, France 0.04
Tsukuba Memorial Hospital, Japan 0.04
Administration Bureau, UTokyo, Japan 0.04
Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (LS-TARA Center), University of Tsukuba, Japan 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER